Many Ways Pharmaceutical Consultants Can Shift Business And Marketing Results

While straightforward economics may dictate that a pharmaceutical company's bottom line is really driven by the need to sell its products for monetary gain, a more holistic view should be taken. The company is in a critical position, market wise in relation to government regulators and the end consumer. This dynamic environment is sometimes difficult to understand and pharmaceutical consultants can definitely benefit the company as it struggles to remain competitive.

Pharmaceutical companies must conform to strict FDA regulations, best use practices and study scientific benchmarks to provide products and services for ongoing use. Marketing plays a critical role in this arrangement and is far more than just a means to an end. The physician or pharmacist has to juggle a lot of information, much of it based on older science, together with the wants and needs of the patient and budgetary restrictions applied by insurance companies or individual positions.

The direct communication between health care professionals and the pharmaceutical companies through various marketing channels ultimately dictates the efficient delivery of products and services to the end-user, the patient. It follows that the standard of this marketing and its effectiveness directly contributes to the patient's ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. In addition to the company's communication with the professional about the benefits and risks associated, the science behind the introduction of the products and ways for dissemination and consumption, the professional also communicates back to the company with feedback, real-time findings and data.

The contribution of pharma consulting should never be underestimated as it can help to emphasise how certain conditions can be treated by emerging products and help to reveal how other illnesses, previously under-served, could be addressed. Where treatment gaps may have previously existed, the research and work done by the pharmaceutical companies can also raise awareness and enable treatment for patients who may not have realised the treatment was available. Just because the pharmaceutical products may exist, it does not mean that these products will find their way into the hands of the consumer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.

As more and more information is revealed through scientific study, product creation and government rubber-stamping, more of a spotlight is turned on the need for treatment of chronic diseases. As such, any by-products or side effects of new solutions may not become known, nor the link between cure and original illness exposed, unless strong marketing channels are open between all concerned.

Generally, pharmaceutical consulting firms are highly skilled at developing communication between vital parties and educating all players. Their interaction, encouragement and foresight can help to ensure that the marketing machine is primed and key players are aware of each other's vital contributions, so important in this hyper-competitive environment.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.